DOI:

EAPCI Focus on the Cypriot Interventional Cardiology Working Group of the Cypriot Society of Cardiology (CSC)

NEWS

Fellows course: 9-11 June 2016 at the Heart House, Sophia Antipolis, France. This course is designed to aid the continued development of medical doctors who have started or have recently completed a programme of training in interventional cardiology in the core subjects of the syllabus. Register now.

Attend the EAPCI General Assembly on Tuesday 17 May from 17:15 to 18:45, at the occasion of EuroPCR 2016 and hear, amongst others, the EAPCI Board elections results. Access the scientific programme of EuroPCR for further information concerning this session.

EAPCI Focus on the Cypriot Interventional Cardiology Working Group of the Cypriot Society of Cardiology (CSC)

An interview with the President, Savvas S. Constantinides

What does EAPCI membership mean for the national society?

EAPCI membership is practically universal amongst Cypriot interventionists. For a small country like ours, being part of the EAPCI is important for exchanging knowledge and experience, particularly at EuroPCR. Cyprus has seven cathlabs (six centres) with a one cathlab/120,000 population ratio. Despite our size, we have been able to promote our work and share our experience at EuroPCR through joint sessions, this year with Greece and the UK.

Current issues related to the national society?

In Cyprus, interventional cardiology is not recognised as a subspecialty. The Interventional Cardiology Working Group is relatively new and its activities are mainly performed under the auspices of the Cyprus Cardiological Society. Primary PCI, although it began many years ago, has failed to penetrate on a national basis, and STEMI treatment still depends on the geographical area of presentation. Cyprus is a member of the Stent for Life initiative. The establishment of our Working Group has brought local interventional cardiologists together. We organise regular case presentations and meetings for topic discussions and, in the last two years, we have hosted the “Cyprus Transradial Course”, an international course for radial intervention with the participation of local and international authorities within this field.

Future vision, expectations and hopes related to the national society?

We are aiming to expand primary PCI throughout the country, eliminating the unacceptable geographical differences in the management of STEMI. Through establishing a national registry for ACS, which will start running this year, we are hoping to highlight these inequalities and put pressure on the Ministry of Health to expand primary PCI to all areas involving both the public as well as the private sector within an organised National Health System. In addition, we are working on the establishment of a national PCI registry involving all practising interventional cardiology centres, and finally we hope to expand TAVI uptake which is presently limited due to reimbursement issues. The Government is committed to establishing a formal National Health System which would hopefully cover all people living in a “unified” Cyprus, equally involving the public and private sectors in a way that would improve the availability and uniformity of interventional cardiology practice in Cyprus.

Savvas S. Constantinides, President of the Cyprus Interventional Society Working Group

President: Savvas S. Constantinides

Vice-President: Christos Eftychiou

Contact details: [email protected]

Website: http://cycardio.com/

Upcoming annual meeting: Case and topic presentation meetings quarterly. Transradial meeting once a year (October)

Founded: 1977 (CSC); 2010 (WG)

Members: 16 (WG)

EAPCI Members: 15

Volume 11 Number 13
Apr 20, 2016
Volume 11 Number 13
View full issue


Key metrics

On the same subject

10.4244/EIJV12I3A49 Jun 20, 2016
EAPCI, a new team, but the same commitment!
Haude M
free

EAPCI Column

Mar 4, 2024
Focus on EAPCI joint sessions
free

10.4244/EIJV15I5A74 Aug 29, 2019
Working across borders: EAPCI and the National Societies
Baumbach A
free

10.4244/EIJV13I17A326 Apr 20, 2018
May in Paris! Join us! EuroPCR 2018
Haude M
free

10.4244/EIJV12I12A239 Dec 20, 2016
Building the future together
Haude M
free
Trending articles
338.03

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
284.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.15

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved